Compound: Motesanib

Drug Target: VEGFR, RET, KIT, PDGFR

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.